Clinical Trials Logo

Clinical Trial Summary

A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session applied on every other day for 14 weeks.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03938948
Study type Interventional
Source Awareable Technologies Inc
Contact Elinor Chang
Phone 7134876230
Email admin@awareable.ai
Status Recruiting
Phase N/A
Start date April 11, 2019
Completion date December 2022

See also
  Status Clinical Trial Phase
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Completed NCT01451021 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Completed NCT01451138 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) Phase 2
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Completed NCT01451177 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) Phase 2
Completed NCT01451125 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) Phase 2
Recruiting NCT06333600 - Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss Phase 1/Phase 2
Not yet recruiting NCT05409755 - Radiofrequency in Female Pattern Hair Loss N/A
Not yet recruiting NCT05888922 - Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia Phase 3
Completed NCT01669746 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) Phase 2
Completed NCT01451099 - A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Completed NCT01451190 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) Phase 2
Completed NCT01451047 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) Phase 2
Not yet recruiting NCT05824065 - Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss Phase 3
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Completed NCT01451073 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) Phase 2
Completed NCT01451151 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) Phase 2
Completed NCT04898166 - Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).